Daniel Sharp

Botanix Pharmaceuticals Ltd | Non-Executive Director

Mr Sharp has 30 years of experience in capital markets globally, advising the boards of technology and healthcare-based organisations. He has experience in sourcing and servicing institutional and private wealth investors globally. He was a Corporate Finance Executive Director of Canaccord Genuity for 8 years and previously spearheaded the Corporate Finance departments at Shaw and Partners and Lodge Partners. He is chair of the risk committee.

Companies and Roles

Company	Title	Tenure	Since
BOT Botanix Pharmaceuticals Ltd	Non-Executive Director	4yrs, 2mth	Mar 2022
ALC Alcidion Group Limited	Non-Executive Director	4yrs, 9mth	Sep 2021

Holdings

Company	Last Notice	Direct Shares	Indirect Shares	Options	Convertibles
BOT Botanix Pharmaceuticals Ltd	20/04/26	5,242,458	2,964,646	4,833,333	N/A
ALC Alcidion Group Limited	30/06/25	578,572	800,000	N/A	N/A

Transactions

Company	Date	Type	Amount	Price	Value	Notes
BOT Botanix Pharmaceuticals Ltd	20/04/26	Issued	833,333	$0.035	$29,166	Placement
BOT Botanix Pharmaceuticals Ltd	10/04/26	Issued	833,333	$0.060	$49,999	Placement
BOT Botanix Pharmaceuticals Ltd	20/03/25	Issued	3,111,145	$0.435	$1,353,348	Exercise of options
BOT Botanix Pharmaceuticals Ltd	20/03/25	Exercise	4,000,000	$0.435	$1,740,000	Exercise of options
BOT Botanix Pharmaceuticals Ltd	02/12/24	Issued	3,000,000	$0.350	$1,050,000	Issue of securities

Any feedback about this profile? Contact Us

Build your watchlist

Already have account? Log in